Colicin E9: Difference between revisions
No edit summary |
mNo edit summary |
||
| Line 3: | Line 3: | ||
==Synthesis and release== | ==Synthesis and release== | ||
Colicin E9 in solution, ie in the cytoplasm after synthesis, is monomeric, and forms a high affinity complex with its immunity protein, Im9. The immunity protein does not directly bind to the active site, but instead to an exosite. This is bound while in the producing cell to protect it from the activity<ref> PMID: 15044477 </ref>. | Colicin E9 in solution, ie in the cytoplasm after synthesis, is monomeric, and forms a high affinity complex with its immunity protein, [[Im9]]. The immunity protein does not directly bind to the active site, but instead to an exosite. This is bound while in the producing cell to protect it from the activity<ref> PMID: 15044477 </ref>. | ||
==Mechanism of uptake== | ==Mechanism of uptake== | ||